Enfermedad de Crohn - Prevención
Nombres alternativos
Ileocolitis granulomatosa; Ileítis; Enfermedad inflamatoria del intestino; Enfermedad inflamatoria intestinal; Enteritis regional; Crohn, enfermedad de
- Fecha de revisión: 2/20/2008
- Versión en inglés revisada por:Christian Stone, MD, Division of Gastroenterology, Washington University in St. Louis, School of Medicine, St. Louis, MO. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.
- Traducción y localización realizada por: DrTango, Inc
Referencias
US Food and Drug Administration. FDA Approves New Treatment For Crohn's Disease. Rockville, MD: National Press Office; February 27, 2007: Report P07-30.
Sandborn WJ, Hanauer SB, Rutgeerts PJ, et al. Adalimumab for Maintenance Treatment of Crohn's Disease: Results of the CLASSIC II Trial. Gut. 2007 Feb 13 [Epub ahead of print].
Gardiner KR. Operative management of small bowel Crohn's disease. Surg Clin North Am. 2007; 87 (3): 587-610.
Graham L. AGA Reviews the Use of Corticosteroids, Immunomodulators, and Infliximab in IBD. Am Fam Physician. 2007; 75 (3): 410-412.